Donoghue Forlines LLC Takes $2.96 Million Position in Cardinal Health, Inc. $CAH

Donoghue Forlines LLC purchased a new position in Cardinal Health, Inc. (NYSE:CAH) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 17,602 shares of the company’s stock, valued at approximately $2,957,000. Cardinal Health accounts for about 0.8% of Donoghue Forlines LLC’s investment portfolio, making the stock its 13th biggest holding.

A number of other hedge funds also recently bought and sold shares of CAH. Greykasell Wealth Strategies Inc. acquired a new position in shares of Cardinal Health during the 1st quarter worth approximately $26,000. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC increased its holdings in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after acquiring an additional 75 shares in the last quarter. NewSquare Capital LLC raised its position in Cardinal Health by 100.0% during the second quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after acquiring an additional 107 shares during the period. Finally, GW&K Investment Management LLC raised its position in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after acquiring an additional 144 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CAH shares. Wells Fargo & Company boosted their target price on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Evercore ISI boosted their price objective on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Jefferies Financial Group set a $220.00 target price on Cardinal Health and gave the company a “buy” rating in a research report on Monday, November 3rd. Leerink Partners boosted their price target on Cardinal Health from $187.00 to $211.00 in a research report on Friday, October 31st. Finally, Citigroup raised their price objective on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a report on Friday, October 31st. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $205.00.

Cardinal Health Stock Performance

NYSE:CAH opened at $205.94 on Friday. Cardinal Health, Inc. has a one year low of $114.60 and a one year high of $207.47. The stock has a market cap of $48.93 billion, a PE ratio of 31.93, a P/E/G ratio of 1.39 and a beta of 0.72. The stock has a 50 day moving average price of $164.46 and a 200 day moving average price of $158.49.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. During the same period last year, the company earned $1.88 EPS. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s payout ratio is 30.77%.

Insiders Place Their Bets

In related news, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.